EMEva María Martín‐Suárez

Eva María Martín‐Suárez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eva María Martín‐Suárez has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of central corneal thickness in dogs measured by ultrasound pachymetry and ultrasound biomicroscopy

    by Eva Martín-Suárez, Alba Galán, Juan Morgaz, Alicia Guisado, José María Gallardo, Rafael Jesús Gómez-Villamandos


  • Bilateral typical complete colobomas in a donkey: Retinographic and fluorangiographic description

    by Eva María Martín‐Suárez, Alba Galán, José María Gallardo Galero, Jose María Molleda

    An 18-year-old male donkey was referred with a history of blindness. On ocular examination a complete bilateral typical colobomatous defect involving iris, ciliary body, lens, choroid, retina and optic nerve was observed. An optic pit was presented at the temporal side of the right optic head. Ophthalmoscopic and fluorangiographic characteristics are described.


  • Open Access

    Fluorangiographic study of the ocular fundus in normal horses

    by José M. Molleda, Isabel Cervantes, Alba Galán, Rodrigo Tardón, José M. Gallardo, Eva M. Martín‐Suárez

    Purpose:  To describe the protocol and appearance of fluorescein angiography (FA) in normal horses. Animals:  A total of 25 healthy horses aged between 5 and 15 years. Materials and Methods:  The horses were sedated with 15 µg/kg detomidine and 50 µg/kg butorphanol and dilated with topical tropicamide 1%. All angiograms were recorded after intravenous bolus injection of 10 mg/kg of fluorescein sodium solution. Results:  Two successive angiographic phases could be discerned: the choriopapillary phase, starting at 46.95 ± 9.48 s, and the retinal vascular phase, starting at 47.79 ± 10.38 s. The retinal vascular phase was divided in three parts: filling phase , maximum fluorescence point , and fading phase . During the filling phase, the dye progressed into the retinal vessels, obtaining maximum fluorescence at 59.79 ± 10.39 s, termed the maximum fluorescence point. The fading phase started immediately following the maximum fluorescence point. During this phase, vascular fluorescence decreased to complete reduction at 74.76 ± 9.81 s. Also, areas of delayed choroidal filling, the presence of short retinal vessels in the ventral region of the optic disc, and a particular filling of the optic disc were also observed. Conclusions:  The normal angiographic sequence was described in horses. FA may be a useful method for studying the integrity of the blood–retinal barriers in horses.


  • Comparative fluorescein angiography of the normal sheep and goat ocular fundi

    by Alba Galán, Eva M. Martín‐Suárez, M. Mar Granados, José M. Gallardo, José M. Molleda

    Fluorescein angiography without sedative or anesthetic agents was evaluated in 20 normal goats and 20 normal sheep. All of the angiographic phases were observed using 20 mg/kg fluorescein IV in both species. Fundus fluorescein angiography results revealed wide stars of Winslow in the tapetal fundus, central or marginal flow during the first part of the arterial phase, delayed filling of the focal areas in the choroid near the optic disc that often coincided with others in the disc, and lack of evidence of the 'striate area' in the tapetal fundi. In goats, the angiographic times were 6.54+/-1.25 s for the arterial phase (TA), 7.80+/-1.37 s for the arterio-venous phase (TAV), and 14.13+/-2.01 s for the venous phase (TV). I1: 1.30+/-0.30 s (time elapsing between TA and TAV), and I2: 6.20+/-1.60 s (time elapsing between TAV and TV). In sheep, times were 9.54+/-2.18 s TA, 11.73+/-2.10 s TAV, and 20.86+/-2.74 s TV. I1: 2.04+/-0.75 s and I2: 8.98+/-2.47 s, respectively. Due to the large size of the fundic vessels in sheep and goats, fluorescein angiography of the retinal vasculature can facilitate the study of the different vascular diseases in these species.